Evidence map›Paper›PMID 20926576›Full record

ArticleJournal of virology2010

Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.

Won-Kyung Cho, Moon Kyoo Jang, Keven Huang, Cynthia A Pise-Masison, John N Brady

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Latency Reversing Agents: Kick and Kill of HTLV-1?International journal of molecular sciences · 2021
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. P-TEFb goes viral.Inside the cell · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Won-Kyung ChoVirus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, 41 Medlars Dr., Bethesda, MD 20892, USA. wonkyungc@gmail.com
Moon Kyoo Jang
Keven Huang
Cynthia A Pise-Masison
John N Brady
Center for Cancer Research · USCancer Institute (WIA) · INNational Institutes of Health · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Positive transcription elongation factor b (P-TEFb) plays an important role in stimulating RNA polymerase II elongation for viral and cellular gene expression. P-TEFb is found in cells in either an active, low-molecular-weight (LMW) form or an inactive, high-molecular-weight (HMW) form. We report here that human T-lymphotropic virus type 1 (HTLV-1) Tax interacts with the cyclin T1 subunit of P-TEFb, forming a distinct Tax/P-TEFb LMW complex. We demonstrate that Tax can play a role in regulating the amount of HMW complex present in the cell by decreasing the binding of 7SK snRNP/HEXIM1 to P-TEFb. This is seen both in vitro using purified Tax protein and in vivo in cells transduced with Tax expression constructs. Further, we find that a peptide of cyclin T1 spanning the Tax binding domain inhibits the ability of Tax to disrupt HMW P-TEFb complexes. These results suggest that the direct interaction of Tax with cyclin T1 can dissociate P-TEFb from the P-TEFb/7SK snRNP/HEXIM1 complex for activation of the viral long terminal repeat (LTR). We also show that Tax competes with Brd4 for P-TEFb binding. Chromatin immunoprecipitation (ChIP) assays demonstrated that Brd4 and P-TEFb are associated with the basal HTLV-1 LTR, while Tax and P-TEFb are associated with the activated template. Furthermore, the knockdown of Brd4 by small interfering RNA (siRNA) activates the HTLV-1 LTR promoter, which results in an increase in viral expression and production. Our studies have identified Tax as a regulator of P-TEFb that is capable of affecting the balance between its association with the large inactive complex and the small active complex.

Indexed as

Blotting, WesternBromodomain Containing ProteinsCell Cycle ProteinsCell NucleusChromatin ImmunoprecipitationCyclin TFlow Cytometrygag Gene Products, Human Immunodeficiency VirusGene Products, taxHeLa CellsHTLV-I InfectionsHumansHuman T-lymphotropic virus 1Molecular WeightNuclear ProteinsPositive Transcriptional Elongation Factor BBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsCyclin Tgag Gene Products, Human Immunodeficiency VirusGene Products, taxHEXIM1 protein, humanNuclear Proteinsp19 protein, Human T-lymphotropic virus 1Positive Transcriptional Elongation Factor BRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, MessengerRNA, Small Interferingtax protein, Human T-lymphotrophic virus 1Transcription Factors

Identifiers

PMID20926576
PMCPMC3004308
OpenAlexW2121218527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.